Furthermore, during the new technology era from 1996 onward, available SEER data documents that cervical cancer
incidence in the U.S. has continued to significantly decline
along with the introduction of liquid-based cytology, computer-assisted screening and adjunctive testing for carcinogenic human papillomavirus (HPV)